Beta-lactone compounds

Abstract

The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof:

wherein R is an alkyl group, and R1 comprises at least one moiety selected from a group consisting of an alkyl, an alkenyl, an aryl, a heterocycle, hydroxyl, ester, amido, aldehyde, and a halogen.